EPO Patents = 1

Forward Citations = 7

Loading Chart...

3 inventors (with patents filed for the assignee):

Hong Hoi Ting (5 out of 5 patents)

Chung Lim Wong (5 out of 5 patents)

Wenhua Huang (2 out of 4 patents)

5 patents: Sort by Forward Citations

1. 12083193 - Anti-Her2 nanobody and coding sequence and use thereof (2024-09-10),

2. 11642418 - Use of radiolabeled nanobody in prognosis and diagnosis of cancer (2023-05-09),

3. 11517632 - Anti-Her2 single chain antibody and coding sequence and use thereof (2022-12-06),

4. 11466085 - Anti-PD-L1 nanobody, coding sequence and use thereof (2022-10-11),

5. 10556954 - Anti-PD-L1 nanobody, coding sequence and use thereof (2020-02-11),

Company Overview

Nanomab Technology Limited is a leading biotechnology company specializing in the development of innovative nanomedicines for targeted cancer therapy. Our proprietary platform enables the design and production of highly specific antibodies for precision medicine applications. With a focus on personalized oncology treatments, Nanomab is dedicated to improving patient outcomes and advancing the field of precision medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#593 in Hong Kong

#5,255 in China

Hong Kong, China

Nanomab Technology Limited

Forward Citations = 7

3 inventors:

Hong Hoi Ting (5 out of 5 patents)

Chung Lim Wong (5 out of 5 patents)

Wenhua Huang (2 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nanomab Technology Limited. Retrieved from https://idiyas.com/company/nanomab-technology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]